成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 61700-61-6 Chemical Structure| 61700-61-6
Chemical Structure| 61700-61-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 61700-61-6

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 61700-61-6 ]

CAS No. :61700-61-6
Formula : C8H6N2O2
M.W : 162.15
SMILES Code : O=C(C1=CC2=C(NN=C2)C=C1)O
MDL No. :MFCD06804570
InChI Key :MAVGBUDLHOOROM-UHFFFAOYSA-N
Pubchem ID :4248454

Safety of [ 61700-61-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 61700-61-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 9
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 2.0
Molar Refractivity 43.05
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

65.98 ?2

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.55
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.21
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.26
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.72
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.38
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.02

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.1
Solubility 1.3 mg/ml ; 0.00801 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.19
Solubility 1.04 mg/ml ; 0.00642 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.27
Solubility 0.863 mg/ml ; 0.00532 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.43 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.14

Application In Synthesis of [ 61700-61-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 61700-61-6 ]

[ 61700-61-6 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 61700-61-6 ]
  • [ 1086391-06-1 ]
  • 2
  • [ 98121-41-6 ]
  • [ 61700-61-6 ]
  • [ 1619884-66-0 ]
YieldReaction ConditionsOperation in experiment
93% With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In methanol; at 20℃; A solution of the respective 1H-indazole-5-carboxylic acid or 1-alkyl-1H-indazole-5-carboxylic acid (1 or 7, 10, 1.0 mmol), 3,4-dichaloaniline or <strong>[98121-41-6]5,6-dichloropyridin-3-amine</strong> (-5 or 6,1.1-1.2 mmol), N-ethyl-N-(3-dimethylaminopropyl)carbodiimidehydrochloride (EDC-HCl, 1.0-1.2 mmol) in methanol (5.0 mL) wasstirred over night at room temperature. The reaction was thenpoured into water (10 mL), stirred for 30 min at room temperature,filtered, washed with water (3 x 10 mL), and then dried at 70 C.The crude product was purified by column chromatography onsilica gel (mobile phase: dichloromethane/MeOH 9/1 v/v) following by recrystallization from petroleum ether/dichloromethane. 4.1.2.1. N-(5,6-dichloropyridin-3-yl)-1H-indazole-5-carboxamide(14). Off-white-greyish solid (125 mg, 93%); mp > 290 C (dec.). 1HNMR (500 MHz, DMSO-d6) delta 7.67 (d, J 8.82 Hz, 1H, Ph), 8.05 (d,J 8.51 Hz, 1H, Ph), 8.21 (s, 1H, Ind.-Het.), 8.34 (s, 1H, Pyr.), 8.44 (s,1H, Ph), 8.74 (s, 1H, Pyr), 12.8 (s, 1H, CONH), 13.55 (s, 1H, NH). 13CNMR (125 MHz, DMSO-d6) delta 110.1, 111.1, 120.5, 123.0, 123.2, 123.9,126.3, 126.7, 127.1, 135.3, 136.1, 141.4, 163.1. ESI-MS (m/z): calcd. forC13H8Cl2N4O: 306.008; found 305.121 [M H]e, 307.301 [M H].
  • 3
  • [ 61700-61-6 ]
  • [ 885521-46-0 ]
YieldReaction ConditionsOperation in experiment
84% With iodine; potassium hydroxide; In N,N-dimethyl-formamide; at 25℃; for 3h; Into a 25-mL round-bottom flask was placed 1 H-indazole-5-carboxylic acid (200 mg, 1.23 mmol), Nu,Nu-dimethylformamide (3 ml_), potassium hydroxide (138 mg, 2.46 mmol) and iodine (470 mg, 1.85 mmol). The solution was stirred for 3 h at 25C. The reaction was quenched by the addition of 10 mL of Na2S203. The pH value of the solution was adjusted to 6 with hydrogen chloride solution (10 %). The solids were collected by filtration. This resulted in 300 mg (84%) of 3-iodo-1 H-indazole-5-carboxylic acid as a white solid
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 61700-61-6 ]

Carboxylic Acids

Chemical Structure| 704-91-6

A187991 [704-91-6]

1H-Indazole-6-carboxylic acid

Similarity: 1.00

Chemical Structure| 1031417-41-0

A313129 [1031417-41-0]

7-Methyl-1H-indazole-5-carboxylic acid

Similarity: 0.94

Chemical Structure| 677306-38-6

A503101 [677306-38-6]

1H-Indazole-4-carboxylic acid

Similarity: 0.94

Chemical Structure| 787580-93-2

A207407 [787580-93-2]

3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid

Similarity: 0.93

Chemical Structure| 677304-69-7

A157120 [677304-69-7]

1H-Indazole-7-carboxylic acid

Similarity: 0.91

Related Parent Nucleus of
[ 61700-61-6 ]

Indazoles

Chemical Structure| 704-91-6

A187991 [704-91-6]

1H-Indazole-6-carboxylic acid

Similarity: 1.00

Chemical Structure| 1031417-41-0

A313129 [1031417-41-0]

7-Methyl-1H-indazole-5-carboxylic acid

Similarity: 0.94

Chemical Structure| 677306-38-6

A503101 [677306-38-6]

1H-Indazole-4-carboxylic acid

Similarity: 0.94

Chemical Structure| 787580-93-2

A207407 [787580-93-2]

3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid

Similarity: 0.93

Chemical Structure| 473416-12-5

A432555 [473416-12-5]

Methyl 1H-indazole-5-carboxylate

Similarity: 0.93